Evidence of a net release of tissue-type plasminogen activator across the human cerebral vasculature

Thrombosis and Haemostasis

Volumn 91, Issue 5, 2004, Pages 1019-1025

  Jern, Christina ^a   Blomstrand, Christian ^a   Westerlind, Anne ^b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Cerebral blood flow; Endothelium; Plasminogen activator inhibitor type 1; Release; Tissue type plasminogen activator

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; TISSUE PLASMINOGEN ACTIVATOR;

ADRENERGIC STIMULATION; ADRENERGIC SYSTEM; ADULT; AGED; ARTICLE; BLOOD FLOW VELOCITY; BLOOD SAMPLING; BRAIN BLOOD VESSEL; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DOPPLER ECHOGRAPHY; ELECTIVE SURGERY; HUMAN; JUGULAR VEIN; MALE; MIDDLE CEREBRAL ARTERY; PRIORITY JOURNAL; PROTEIN SECRETION; RADIAL ARTERY; REGULATORY MECHANISM; STATISTICAL SIGNIFICANCE; STERNOTOMY;

EID: 2442540020     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/th03-11-0693     Document Type: Article

References (42)

1. Wun T-C, Capuano A. Spontaneous fibrinolysis in whole human plasma. Identification of tissue activator-related protein as the major plasminogen activator causing spontaneous activity in vitro. J Biol Chem 1985; 260: 5061-6.
2. Emeis JJ. Regulation of the acute release of tissue-type plasminogen activator from the endothelium by coagulation activation products. Ann N Y Acad Sci 1992; 667: 249-58.
3. van den Eijnden-Schrauwen Y, Kooistra T, de Vries RE, et al. Studies on the acute release of tissue-type plasminogen activator from human endothelial cells in vitro and in rats in vivo: evidence for a dynamic storage pool. Blood 1995; 85: 3510-7.
4. Jern C, Eriksson E, Tengborn L, et al. Changes of plasma coagulation and fibrinolysis in response to mental stress. Thromb Haemost 1989; 62: 767-71.
5. Larsson PT, Wiman B, Olsson G, et al. Influence of metroprolol treatment on sympatho-adrenal activation of fibrinolysis. Thromb Haemost 1990; 63: 482-7.
6. Chandler WL, Levy WC, Stratton JR. The circulatory regulation of TPA and UPA secretion, clearance, and inhibition during exercise and during the infusion of isoproterenol and phenylephrine. Circulation 1995; 92: 2984-94.
7. von Kanel R, Dimsdale JE. Effects of sympathetic activation by adrenergic infusions on hemostasis in vivo. Eur J Haematol 2000; 65: 357-69.
8. de Boer A, Kluft C, Kroon JM, et al. Liver blood flow as the major determinant of the clearance of recombinant human tissue-type plasminogen activator. Thromb Haemost 1992; 67: 83-7
9. Emeis J. Normal and abnormal endothelial release of tissue-type plasminogen activator. In: Glas-Greenwalt P, editor. Fibrinolysis in disease. Boca Raton: CRC Press; 1995. p. 55-64.
10. Jern C, Selin L, Jern S. In vivo release of tissue-type plasminogen activator across the human forearm during mental stress. Thromb Haemost 1994; 72: 285-91.
11. Jern S, Selin L, Bergbrant A, et al. Release of tissue-type plasminogen activator in response to muscarinic receptor stimulation in human forearm. Thromb Haemost 1994; 72: 588-94.
12. Jern C, Selin L, Tengborn L, et al. Sympathoadrenal activation and muscarinic receptor stimulation induce acute release of tissue-type plasminogen activator but not von Willebrand factor across the human forearm. Thromb Haemost 1997; 78: 887-91.
13. Stein CM, Brown N, Vaughan DE, et al. Regulation of local tissue-type plasminogen activator release by endothelium-dependent and endothelium-independent agonists in human vasculature. J Am Coll Cardiol 1998; 32: 117-22.
14. Jern C, Seeman-Lodding H, Biber B, et al. An experimental multiple-organ model for the study of regional net release/uptake rates of tissue-type plasminogen activator in the intact pig. Thromb Haemost 1997; 78: 1150-6.
15. Seeman-Lodding H, Häggmark S, Jern C, et al. Systemic levels and preportal organ release of tissue-type plasminogen activator are enhanced by PEEP in the pig. Acta Anaesthesiol Scand 1999; 43: 623-33.
16. Österlund B, Holmgren A, Häggmark S, et al. Surgical stress induces acute coronary release of tissue-type plasminogen activator in the pig. Acta Anaesthesiol Scand 2000; 44: 1226-31.
17. Björkman JA, Jern S, Jern C. Cardiac sympathetic nerve stimulation triggers coronary t-PA release. Arterioscler Thromb Vasc Biol 2003; 23: 1091-7.
18. Kirnö K, Friberg P, Grzegorczyk A, et al. Thoracic epidural anesthesia during coronary artery bypass surgery: Effects on cardiac sympathetic activity, myocardial blood flow and metabolism, and central hemodynamics. Anesth Analg 1994; 79: 1075-81.
19. Newby DE, Wright RA, Labinjoh C, et al. Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking. A mechanism for arterial thrombosis and myocardial infarction. Circulation 1999; 99: 1411-5.
20. Newby DE, McLeod AL, Uren NG, et al. Impaired coronary tissue plasminogen activator release is associated with coronary atherosclerosis and cigarette smoking: direct link between endothelial dysfunction and atherothrombosis. Circulation 2001; 103: 1936-41.
21. Rånby M, Nguyen G, Scarabin PY, et al. Immunoreactivity of tissue plasminogen activator and of its inhibitor complexes. Thromb Haemost 1989; 61: 409-14.
22. Meijer P, Pollet DE, Wauters J, et al. Specificity of antigen assays of plasminogen activator inhibitor in plasma: Innotest PAI-1 immunoassay evaluated. Clin Chem 1994; 40: 110-5.
23. Wall U, Jern S, Tengborn L, et al. Evidence of a local mechanism for desmopressin-induced tissue-type plasminogen activator release in human forearm. Blood 1998; 91: 529-37.
24. Gough SCL, Smyllie J, Sheldon J, et al. The anatomical distribution of plasma fibrinolytic activity in man during cardiac catheterization. Thromb Haemost 1992; 68: 442-7.
25. Sorteberg W. Cerebral artery blood velocity and cerebral blood flow. In: Transcranial Doppler. Newell DW, Aaslid eds, Raven Press, Ltd., New York 1992, pp 57-66.
26. Wang Y, Jiang X, Hand AR, et al. Additional evidence that the sympathetic nervous system regulates the vessel wall release of tissue plasminogen activator. Blood Coagul Fibrinolysis 2002; 13: 471-81.
27. Jern S, Wall U, Bergbrant A, et al. Endothelium-dependent vasodilation and tissue type plasminogen activator release in borderline hypertension. Arterioscler Thromb Vasc Biol 1997; 17: 3376-83.
28. Newby DE, Wright RA, Ludlam CA, et al. An in vivo model for the assessment of acute fibrinolytic capacity of the endothelium. Thromb Haemost 1997; 78: 1242-8.
29. Minai K, Matsumoto T, Horie H, et al. Bradykinin stimulates the release of tissue plasminogen activator in human coronary circulation: effects of angiotensin-converting enzyme inhibitors. J Am Coll Cardiol 2001; 37: 1565-70.
30. Chandler WL, Alessi MC, Aillaud MF, et al. Clearance of tissue plasminogen activator (TPA) and TPA/plasminogen activator inhibitor type 1 (PAI-1) complex: relationship to elevated TPA antigen in patients with high PAI-1 activity levels. Circulation 1997; 96: 761-8.
31. Olofsson BO, Dahlén G, Nilsson TK. Evidence for increased levels of plasminogen activator inhibitor and tissue plasminogen activator in plasma of patients with angiographically verified coronary artery disease. Eur Heart J 1989; 10: 77-82.
32. Loskutoff DJ, Sawdey M, Keeton M, et al. Regulation of PAI-1 gene expression in vivo. Thromb Haemost 1993; 70: 135-7.
33. Chomiki N, Henry M, Alessi MC, et al. Plasminogen activator inhibitor-1 expression in human liver and healthy or atherosclerotic vessel walls. Thromb Haemost 1994; 72: 44-53.
34. Ridker PM, Hennekens CH, Stampfer MJ, Manson JE, Vaughan DE. Prospective study of endogenous tissue plasminogen activator and risk of stroke. Lancet 1994; 343: 940-3.
35. Larsen FS, Olsen KS, Hansen BA, et al. Transcranial Doppler is valid for determination of the lower limit of cerebral blood flow autoregulation. Stroke 1994; 25: 1985-8.
36. Newell DW, Aaslid R, Lam A, et al. Comparison of flow and velocity during dynamic autoregulation in humans. Stroke 1994; 25: 793-7.
37. Hrafnkelsdóttir T, Wall U, Jern C, et al. Impaired capacity for endogenous fibrinolysis in essential hypertension. Lancet 1998; 352: 1597-8.
38. Österlund B. Coronary release of t-PA. An experimental and clinical study. Thesis, Umeå University, Sweden, 2002.
39. Wang X, Xu L, Wang H, Grzanna R, Zhan Y et al. Inhibition of factor Xa reduces ischemic brain damage after thromboembolic stroke in rats. Stroke 2003; 34: 468-74.
40. Levin EG, del Zoppo GJ. Localization of tissue plasminogen activator in the endothelium of a limited number of vessels. Am J Pathol 1994; 144: 855-61.
41. Schreiber SS, Tan Z, Sun N, et al. Immunohistochemical localization of tissue plasminogen activator in vascular endothelium of stroke-prone regions of the rat brain. Neurosurgery 1998; 43: 909-13.
42. Strickland S. Tissue plasminogen activator in nervous system function and dysfunction. Thromb Haemost 2001; 86: 138-43.